Chemical compound produces beneficial inflammation, remyelination that could help treat multiple sclerosis: Study shows that ‘good inflammation’ promotes axon myelination

Drugs available to treat multiple sclerosis, a leading cause of neurological disability affecting roughly 2.3 million people worldwide, alter the

Genome’s dark matter offers clues to major challenge in prostate cancer: Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy

The dark matter of the human genome may shed light on how the hormone androgen impacts prostate cancer. Researchers at